– $20.0 million in Revuforj® (revumenib) net revenue in first full quarter of launch – – $13.6 million in Niktimvo™ (axatilimab-csfr)…
Highlights (All comparisons are to the prior year period unless otherwise noted): Net sales of $507.7 million for the quarter,…
Presentation Highlights the Opportunity to Unlock Value for All ISC Shareholders and Reverse Long-Term DeclineBoard Should Meaningfully Engage with Shareholders…
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law…
Revenue is up 19% and recurring EBITDA Increases to €17.4 Million, confirming the year-end guidance issued in October.The United States…
Following the closure of ExtractionTek Stainless and Precision Extraction, Evolved emerges as the financially strong, forward-focused partner—with cross-compatible technology, new…
OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of…
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Northfield Capital Corporation (TSX-V: NFD.A) (“Northfield” or the “Corporation”) is pleased to announce…
Clean power is core to energy and economic securityVancouver, B.C., May 05, 2025 (GLOBE NEWSWIRE) -- In response to the release…
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Vita…
This website uses cookies.